longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Marinus Pharma

MRNS

0.55000.00% ( 0.0000 )
Closed: Sep 21, 09:20:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Marinus Pharma (MRNS)

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare g...

Open
--
High
--
Low
--
Prev. Close
0.5500
Volume
0
Turnover
0
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
--
Volume Ratio
0.00
Turnover Ratio
--
52wk Low
--
Float Mkt Cap
18.98M
Market CapUSD
30.35M
P/ETTM
Loss
P/EDynamic
Loss
P/EStatic
--
EPSTTM
-2.47
EPSDynamic
-2.31
EPSStatic
--
BVPS
-1.21
P/B
--
Circulating Supply
34.52M
Dividend YieldTTM
--
DividendTTM
--
Shares
55.19M
Min lot size
1
Currency
USD

News

  • benzinga_article · Sep 18 at 05:35 PM

    9 Health Care Stocks Whale Activity In Today’s Session

  • benzinga_article · Aug 21 at 10:00 PM

    MRNA, SPCX, MSTR and More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

  • Market Beat · Jul 4 at 11:00 AM

    MarketBeat Week in Review – 06/29 - 07/03

  • Thehill · May 21 at 02:05 PM

    Moderna mRNA flu vaccine to get FDA panel review

  • MarketWatch · May 11 at 05:17 PM

    Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

  • Tip Ranks · May 8 at 06:07 PM

    Moderna (MRNA) Stock Surges 14% on Hantavirus Vaccine. Here's What Investors Should Know